Abstract:Objective To investigate the clinical significance and changes of plasma brain natriuretic peptide(BNP) level in patients with chronic obstructive pulmonary disease(COPD) under different conditions.Methods The clinical data of 72 cases COPD patients who were exacerbated in acute were analyzed retrospectively.According to the diagnosis,the patients were divided into four groups: simple COPD group,COPD combined with pulmonary heart disease in compensated stage group,COPD combined with pulmonary heart disease in heart failure group,and COPD combined with coronary heart disease in heart failure group.The differences of BNP levels among the four groups were compared and their influ ence factors were analyzed.Results Compared with simple COPD group,the levels of plasma BNP of other three groups were significantly increased(t=2.03,9.69,8.45,P<0.05).Compared with COPD combined with pulmonary heart disease in compensatory stage group,the BNP levels in COPD combined with pulmonary heart disease in heart failure group and COPD combined with coronary heart disease in heart failure group were significantly increased(t=7.10,6.09,P<0.05).There was no significant differences of BNP level between COPD combined with pulmonary heart disease in heart failure group and COPD combined with coronary heart disease in heart failure group(t=0.69,P>0.05).The correlation analysis showed that plasma BNP levels was positive related to PaCO_2,pulmonary artery systolic pressure and right ventricular diameter(r =0.62,0.76,0.69,P <0.05)while negative related to PaO_2,FEV_1 /FVC,FEV_1 %(r =-0.51,0.27,-0.28,P <0.05).Multiple stepwise regression analysis showed that the pulmonary artery systolic pressure greatest influenced on BNP level(b′=0.37,P<0.05).Conclusions The changes of plasma BNP levels in different status of COPD patients who were exacerbated in acute are not similar.The determination of plasma BNP level has important significance in diagnosis of COPD combined with heart failure.There may be no obvious difference in BNP levels be tween COPD combined with pulmonary heart disease and COPD combined with coronary heart disease.

Clinical evaluation effect of brain natriuretic peptide in patients with heart failure

Differential Diagnoses Value of Plasama Brain Natriuretic in Patients with Acute Heart Failure

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

Rapid Bedside Assay of B - Type Natriuretic Peptide in Early Diagnosis of Heart Failure

BNP levels and its influencing factors in patients with acute coronary syndrome

Brain Natriuretic Peptide and Optimal Management of Heart Failure.

Plasma Brain Natriuretic Peptide Levels in the Diagnosis of Heart Failure

Plasma Concentration of Brain Natriuretic Peptide and Heart Dysfunction

B type natriuretic peptide apply for dignosis and treatment in patients with congestive heart failure

Clinical significance and changes of plasma brain natriuretic peptide level in patients with chronic obstructive pul monary disease under different conditions

Level of serum brain natriuretic peptide in left ventricular dysfunction and its diagnostic value

Prognosis Value of Sequential B-type Natriuretic Peptide Measurements for Patients Hospitalized with Chronic Congestive Heart Failure

Prognostic Potential of B -Type Natriuetic Peptide and Quality of Life in Patients with Chronic Heart Failure

Study on Heart Function Evaluated by Tei Index and Brain Natriuretic Peptide in Hypertension Patients with Heart Failure

Relationship between N-terminal pro-brain natriuretic peptide and heart failure

B-type natriuretic peptide and platelet parameters change in patients with chronic heart failure

Corelation Between Plasma N-terminal ProBNP(NT-proBNP) and Cardiac Dysfunction

Clinical value of N-terminal proBNP in diagnosis of left heart failure

Influencing factors for plasma natriuretic peptide and N-terminal pro-B-type natriuretic peptide levels in senior patients with heart failure

Changes in Brain Natriuretic Peptide Are Correlated with Changes in Global End-Diastolic Volume Index

The Application of N-terminal Pro-brain B-type Natriuretic Peptides in the Diagnosis of Elderly Patients with Chronic Heart Failure